Journal of Gynecologic Oncology

Papers
(The TQCC of Journal of Gynecologic Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer40
FIGO staging of endometrial cancer: 202326
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer26
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial24
Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis22
Laparoscopic vs. robotic-assisted laparoscopy in endometrial cancer staging: large retrospective single-institution study20
Major clinical research advances in gynecologic cancer in 202020
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies19
Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study19
Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis18
Major clinical research advances in gynecologic cancer in 202118
Safety and efficacy of 3D-printed templates assisted CT-guided radioactive iodine-125 seed implantation for the treatment of recurrent cervical carcinoma after external beam radiotherapy18
Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)17
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer17
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)16
Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome15
Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis15
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer15
Recurrence risk factors in stage IA grade 1 endometrial cancer15
MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas14
LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis14
Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway14
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset13
Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetri13
Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma12
Total laparoscopic vs. conventional open abdominal nerve-sparing radical hysterectomy: clinical, surgical, oncological and functional outcomes in 301 patients with cervical cancer12
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis12
Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment12
The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer12
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study12
A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer11
Financial toxicity in patients with gynecologic malignancies: a cross sectional study11
Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR)10
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic10
Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol 10
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)9
Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–20209
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Onco9
Lymphadenectomy issues in endometrial cancer9
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples9
The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer9
Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer9
Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review8
The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines e8
Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study8
Conditional relative survival of cervical cancer: a Korean National Cancer Registry Study7
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients7
Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary per7
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling7
Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women7
Cancer field surgery in endometrial cancer: peritoneal mesometrial resection and targeted compartmental lymphadenectomy for locoregional control7
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer7
Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction7
Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer7
Why was GOG-0213 a negative trial?7
Current status and future directions of ovarian cancer prognostic models7
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy7
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes7
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review7
A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study6
An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva6
Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study6
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study6
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 20206
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer6
Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer6
Rectosigmoid resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer: morbidity of gynecologic oncology vs. colorectal team6
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial6
Preclinical investigation of patient-derived cervical cancer organoids for precision medicine6
Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma6
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients withBRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemother6
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis6
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry6
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis5
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group5
Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer5
Mapping the robotic hysterectomy learning curve and re-establishing surgical training metrics5
Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory?5
The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate5
Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculum5
Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study5
Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer5
Real-time intraoperative ureter visualization with a novel Near-Infrared Ray Catheter during laparoscopic hysterectomy for gynecological cancer5
SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis5
Molecular classification of endometrial cancer: entering an era of precision medicine5
Time for enhancing government-led primary prevention of cervical cancer5
Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program5
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multice4
What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?4
Epidemiologic study on gestational trophoblastic diseases in Japan4
A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer4
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the 4
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles4
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic4
Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study4
Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea4
Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 20134
Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis4
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis4
Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy4
The extent of aortic lymphadenectomy in locally advanced cervical cancer impacts on survival4
Comments on the utilization of Mann-Whitney U test and Kaplan-Meier method4
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia4
Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritone4
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma4
The current status of laparoscopic and robotic para-aortic lymphadenectomy in gynecologic cancer surgery4
Peripheral bloodBRCA1methylation profiling to predict familial ovarian cancer4
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study4
Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary4
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)4
Sentinel node mapping in endometrial cancer4
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics4
Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix4
0.024031162261963